- Home
- KUKE vs ANEB Comparison
KUKE vs ANEB Comparison
Compare KUKE & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KUKE
- ANEB
- Stock Information
- Founded
- KUKE 2002
- ANEB 2020
- Country
- KUKE China
- ANEB United States
- Employees
- KUKE N/A
- ANEB N/A
- Industry
- KUKE Other Consumer Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- KUKE Real Estate
- ANEB Health Care
- Exchange
- KUKE Nasdaq
- ANEB Nasdaq
- Market Cap
- KUKE 86.8M
- ANEB 90.4M
- IPO Year
- KUKE 2021
- ANEB 2021
- Fundamental
- Price
- KUKE $1.59
- ANEB $2.49
- Analyst Decision
- KUKE
- ANEB Buy
- Analyst Count
- KUKE 0
- ANEB 2
- Target Price
- KUKE N/A
- ANEB $8.00
- AVG Volume (30 Days)
- KUKE 33.7K
- ANEB 127.6K
- Earning Date
- KUKE 10-15-2025
- ANEB 11-12-2025
- Dividend Yield
- KUKE N/A
- ANEB N/A
- EPS Growth
- KUKE N/A
- ANEB N/A
- EPS
- KUKE N/A
- ANEB N/A
- Revenue
- KUKE $9,442,397.00
- ANEB N/A
- Revenue This Year
- KUKE N/A
- ANEB N/A
- Revenue Next Year
- KUKE N/A
- ANEB N/A
- P/E Ratio
- KUKE N/A
- ANEB N/A
- Revenue Growth
- KUKE N/A
- ANEB N/A
- 52 Week Low
- KUKE $1.45
- ANEB $0.80
- 52 Week High
- KUKE $10.00
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- KUKE 39.09
- ANEB 52.45
- Support Level
- KUKE $1.60
- ANEB N/A
- Resistance Level
- KUKE $1.68
- ANEB $2.58
- Average True Range (ATR)
- KUKE 0.17
- ANEB 0.17
- MACD
- KUKE 0.02
- ANEB -0.10
- Stochastic Oscillator
- KUKE 16.80
- ANEB 87.99
About KUKE Kuke Music Holding Limited
Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.